NCT05972070 Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
| NCT ID | NCT05972070 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ROM Technologies, INC |
| Condition | Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-06-01 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.
Eligibility Criteria
Inclusion Criteria: 1. Over the age of 18 2. NYHA Functional Class I, II, 3. Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation) 4. Candidate for traditional center-based cardiac rehabilitation Exclusion Criteria: 1. Under the age of 18 2. Adults lacking capacity to consent. 3. NYHA Functional Class III, IV 4. Acute coronary syndrome 5. Systolic heart failure (LV EF \<40%) 6. Status post cardiac surgery for structural heart disease or heart transplant 7. Percutaneous coronary angioplasty 8. Adults lacking capacity to consent. 9. Pregnant women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05972070 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05972070 currently recruiting?
Yes, NCT05972070 is actively recruiting participants. Contact the research team at Latoya.King@romtech.com for enrollment information.
Where is the NCT05972070 trial being conducted?
This trial is being conducted at Brookfield, United States.
Who is sponsoring the NCT05972070 clinical trial?
NCT05972070 is sponsored by ROM Technologies, INC. The trial plans to enroll 500 participants.